Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schulze-Koops

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Zeitschrift Fur Rheumatologie|May 20, 2016
[Rheumatology - Integration into student training (RISA) : Current structure of clinical rheumatology in German universities (RISA III)]G Riemekasten, M Aringer, C G O Baerwald, et al.
Lupus|September 24, 2013
Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID)M Witt, M Grunke, F Proft, et al.
Zeitschrift Fur Rheumatologie|October 15, 2021
[Development of quality standards for patients with rheumatoid arthritis for use in Germany]U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
Zeitschrift Fur Rheumatologie|December 19, 2015
[Do we still need clinical studies in rheumatology?]U Henkemeier, R Alten, B Bannert, et al.
Zeitschrift Fur Rheumatologie|August 11, 2021
[Development of quality standards for patients with axial spondyloarthritis for use in Germany]U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
Zeitschrift Fur Rheumatologie|June 8, 2017
[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)]F Proft, H Schulze-Koops, M Grunke, et al.
Seminars in Arthritis and Rheumatism|January 1, 2019
Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritisA Heiligenhaus, K Minden, C Tappeiner, et al.
Zeitschrift Fur Rheumatologie|August 30, 2012
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]K Krüger, J Wollenhaupt, K Albrecht, et al.
Zeitschrift Fur Rheumatologie|November 6, 2020
[S2k guidelines (executive summary): management of large-vessel vasculitis]J H Schirmer, P M Aries, K Balzer, et al.
Lupus|November 11, 2011
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus reportM Aringer, H Burkhardt, G R Burmester, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Zeitschrift Fur Rheumatologie|May 20, 2016
[Rheumatology - Integration into student training (RISA) : Current structure of clinical rheumatology in German universities (RISA III)]G Riemekasten, M Aringer, C G O Baerwald, et al.
Lupus|September 24, 2013
Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) - results from a nationwide cohort in Germany (GRAID)M Witt, M Grunke, F Proft, et al.
Zeitschrift Fur Rheumatologie|October 15, 2021
[Development of quality standards for patients with rheumatoid arthritis for use in Germany]U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
Zeitschrift Fur Rheumatologie|December 19, 2015
[Do we still need clinical studies in rheumatology?]U Henkemeier, R Alten, B Bannert, et al.
Zeitschrift Fur Rheumatologie|August 11, 2021
[Development of quality standards for patients with axial spondyloarthritis for use in Germany]U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
Zeitschrift Fur Rheumatologie|June 8, 2017
[Safety and efficacy of off-label use of biologic therapies in patients with inflammatory rheumatic diseases refractory to standard of care therapy : Data from a nationwide German registry (GRAID2)]F Proft, H Schulze-Koops, M Grunke, et al.
Seminars in Arthritis and Rheumatism|January 1, 2019
Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritisA Heiligenhaus, K Minden, C Tappeiner, et al.
Zeitschrift Fur Rheumatologie|August 30, 2012
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]K Krüger, J Wollenhaupt, K Albrecht, et al.
Zeitschrift Fur Rheumatologie|November 6, 2020
[S2k guidelines (executive summary): management of large-vessel vasculitis]J H Schirmer, P M Aries, K Balzer, et al.
Lupus|November 11, 2011
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus reportM Aringer, H Burkhardt, G R Burmester, et al.
Pageof 11